185 related articles for article (PubMed ID: 25610812)
1. Coxiella burnetii lipopolysaccharide blocks p38α-MAPK activation through the disruption of TLR-2 and TLR-4 association.
Conti F; Boucherit N; Baldassarre V; Trouplin V; Toman R; Mottola G; Mege JL; Ghigo E
Front Cell Infect Microbiol; 2014; 4():182. PubMed ID: 25610812
[TBL] [Abstract][Full Text] [Related]
2. Primary Role for Toll-Like Receptor-Driven Tumor Necrosis Factor Rather than Cytosolic Immune Detection in Restricting Coxiella burnetii Phase II Replication within Mouse Macrophages.
Bradley WP; Boyer MA; Nguyen HT; Birdwell LD; Yu J; Ribeiro JM; Weiss SR; Zamboni DS; Roy CR; Shin S
Infect Immun; 2016 Apr; 84(4):998-1015. PubMed ID: 26787725
[TBL] [Abstract][Full Text] [Related]
3. Impaired stimulation of p38α-MAPK/Vps41-HOPS by LPS from pathogenic Coxiella burnetii prevents trafficking to microbicidal phagolysosomes.
Barry AO; Boucherit N; Mottola G; Vadovic P; Trouplin V; Soubeyran P; Capo C; Bonatti S; Nebreda A; Toman R; Lemichez E; Mege JL; Ghigo E
Cell Host Microbe; 2012 Dec; 12(6):751-63. PubMed ID: 23245320
[TBL] [Abstract][Full Text] [Related]
4. Coxiella burnetii Lipopolysaccharide: What Do We Know?
Abnave P; Muracciole X; Ghigo E
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29168790
[TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharide from Coxiella burnetii is involved in bacterial phagocytosis, filamentous actin reorganization, and inflammatory responses through Toll-like receptor 4.
Honstettre A; Ghigo E; Moynault A; Capo C; Toman R; Akira S; Takeuchi O; Lepidi H; Raoult D; Mege JL
J Immunol; 2004 Mar; 172(6):3695-703. PubMed ID: 15004173
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of toll-like receptor 2 by Coxiella burnetii is required for macrophage production of pro-inflammatory cytokines and resistance to infection.
Zamboni DS; Campos MA; Torrecilhas AC; Kiss K; Samuel JE; Golenbock DT; Lauw FN; Roy CR; Almeida IC; Gazzinelli RT
J Biol Chem; 2004 Dec; 279(52):54405-15. PubMed ID: 15485838
[TBL] [Abstract][Full Text] [Related]
7. Coxiella burnetii Blocks Intracellular Interleukin-17 Signaling in Macrophages.
Clemente TM; Mulye M; Justis AV; Nallandhighal S; Tran TM; Gilk SD
Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30061378
[No Abstract] [Full Text] [Related]
8. Virulent Coxiella burnetii does not activate human dendritic cells: role of lipopolysaccharide as a shielding molecule.
Shannon JG; Howe D; Heinzen RA
Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8722-7. PubMed ID: 15939879
[TBL] [Abstract][Full Text] [Related]
9. Attenuated Coxiella burnetii phase II causes a febrile response in gamma interferon knockout and Toll-like receptor 2 knockout mice and protects against reinfection.
Ochoa-Repáraz J; Sentissi J; Trunkle T; Riccardi C; Pascual DW
Infect Immun; 2007 Dec; 75(12):5845-58. PubMed ID: 17893129
[TBL] [Abstract][Full Text] [Related]
10. Intracellular life of Coxiella burnetii in macrophages.
Ghigo E; Pretat L; Desnues B; Capo C; Raoult D; Mege JL
Ann N Y Acad Sci; 2009 May; 1166():55-66. PubMed ID: 19538264
[TBL] [Abstract][Full Text] [Related]
11. Genetic mechanisms of Coxiella burnetii lipopolysaccharide phase variation.
Beare PA; Jeffrey BM; Long CM; Martens CM; Heinzen RA
PLoS Pathog; 2018 Mar; 14(3):e1006922. PubMed ID: 29481553
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide of Coxiella burnetii.
Narasaki CT; Toman R
Adv Exp Med Biol; 2012; 984():65-90. PubMed ID: 22711627
[TBL] [Abstract][Full Text] [Related]
13. History and prospects of Coxiella burnetii research.
Hechemy KE
Adv Exp Med Biol; 2012; 984():1-11. PubMed ID: 22711624
[TBL] [Abstract][Full Text] [Related]
14. Robust growth of avirulent phase II Coxiella burnetii in bone marrow-derived murine macrophages.
Cockrell DC; Long CM; Robertson SJ; Shannon JG; Miller HE; Myers L; Larson CL; Starr T; Beare PA; Heinzen RA
PLoS One; 2017; 12(3):e0173528. PubMed ID: 28278296
[TBL] [Abstract][Full Text] [Related]
15. MyD88 Is Required for Efficient Control of
Kohl L; Hayek I; Daniel C; Schulze-Lührmann J; Bodendorfer B; Lührmann A; Lang R
Front Immunol; 2019; 10():165. PubMed ID: 30800124
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation in TLR10 is not associated with chronic Q fever, despite the inhibitory effect of TLR10 on Coxiella burnetii-induced cytokines in vitro.
Ammerdorffer A; Stappers MH; Oosting M; Schoffelen T; Hagenaars JC; Bleeker-Rovers CP; Wegdam-Blans MC; Wever PC; Roest HJ; van de Vosse E; Netea MG; Sprong T; Joosten LA
Cytokine; 2016 Jan; 77():196-202. PubMed ID: 26364993
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in Toll-like receptors-2 and -4 are not associated with disease manifestations in acute Q fever.
Everett B; Cameron B; Li H; Vollmer-Conna U; Davenport T; Hickie I; Wakefield D; Vernon S; Reeves WC; Lloyd AR
Genes Immun; 2007 Dec; 8(8):699-702. PubMed ID: 17855803
[TBL] [Abstract][Full Text] [Related]
18. Coxiella burnetii Requires Host Eukaryotic Initiation Factor 2α Activity for Efficient Intracellular Replication.
Brann KR; Fullerton MS; Voth DE
Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32284364
[No Abstract] [Full Text] [Related]
19. Coxiella burnetii effector proteins that localize to the parasitophorous vacuole membrane promote intracellular replication.
Larson CL; Beare PA; Voth DE; Howe D; Cockrell DC; Bastidas RJ; Valdivia RH; Heinzen RA
Infect Immun; 2015 Feb; 83(2):661-70. PubMed ID: 25422265
[TBL] [Abstract][Full Text] [Related]
20. Coxiella burnetii, the agent of Q fever, stimulates an atypical M2 activation program in human macrophages.
Benoit M; Barbarat B; Bernard A; Olive D; Mege JL
Eur J Immunol; 2008 Apr; 38(4):1065-70. PubMed ID: 18350541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
